Provided by Tiger Fintech (Singapore) Pte. Ltd.

Erasca, Inc.

1.07
-0.1300-10.88%
Post-market: 1.080.0150+1.41%16:14 EDT
Volume:1.58M
Turnover:1.70M
Market Cap:301.68M
PE:-1.54
High:1.15
Open:1.14
Low:1.03
Close:1.20
Loading ...

Erasca Slides As Insider Purchases Lose Another US$84k

Simply Wall St.
·
09 Apr

Erasca (ERAS) Gets a Buy from J.P. Morgan

TIPRANKS
·
30 Mar

Erasca Inc : Raymond James Initiates Coverage With Outperform Rating; Target Price $5

THOMSON REUTERS
·
26 Mar

Raymond James Initiates Erasca at Outperform With $5 Price Target

MT Newswires Live
·
26 Mar

Erasca initiated with an Outperform at Raymond James

TIPRANKS
·
26 Mar

Erasca Announces Three Poster Presentations at the 2025 AACR Annual Meeting

GlobeNewswire
·
26 Mar

Erasca Is Maintained at Buy by Goldman Sachs

Dow Jones
·
21 Mar

Erasca Price Target Maintained With a $6.00/Share by HC Wainwright & Co.

Dow Jones
·
21 Mar

Erasca, Inc. Reports 2024 Financial and Strategic Progress

TIPRANKS
·
21 Mar

Erasca reports Q4 EPS (11c), consensus (13c)

TIPRANKS
·
21 Mar

Erasca Q4 2024 GAAP EPS $(0.11) Beats $(0.12) Estimate

Benzinga
·
21 Mar

BRIEF-Erasca Q4 Basic EPS USD -0.11

Reuters
·
21 Mar

Erasca: Robust Balance Sheet With Cash, Cash Equivalents & Marketable Securities of $440 Mln as of Dec 31, Expected to Fund Operations Into H2 2027

THOMSON REUTERS
·
21 Mar

Erasca Q4 Operating Expenses USD 35.712 Million

THOMSON REUTERS
·
21 Mar

Erasca Reports Fourth Quarter and Full Year 2024 Business Updates and Financial Results

GlobeNewswire
·
21 Mar

Calendar of U.S. Earnings Expected in the Week Ahead

Dow Jones
·
14 Mar

Erasca Coverage Assumed by Morgan Stanley at Overweight

Dow Jones
·
08 Mar

Erasca to Present at the Guggenheim Securities SMID Cap Biotech Conference

GlobeNewswire
·
31 Jan

PFE Stock Rises on Reports of Averting Proxy Fight With Activist Investor

Zacks
·
28 Jan

Erasca (NASDAQ:ERAS) Is In A Good Position To Deliver On Growth Plans

Simply Wall St.
·
21 Jan